Company
Immunai
Record updated 17 September 2026
About
Immunai is mapping the immune system at single-cell resolution using AI and multi-omics data, accelerating drug discovery and unlocking new insights for immunotherapy and precision medicine.
Company
Record updated 17 September 2026
Immunai is mapping the immune system at single-cell resolution using AI and multi-omics data, accelerating drug discovery and unlocking new insights for immunotherapy and precision medicine.
A first look at Immunai’s connections in the VC Catalog database. Sign in with Google to open the interactive map.
Investor VC firms in this preview
VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.